GGrantIndex
Sort

30,917 grants matching tumor microenvironment

A data-driven drug delivery (4D) platform for probing and treating the chemoresistant bone marrow microenvironment

$2,415,000
Michael J Mitchell · University Of Pennsylvania · DP2 · FY2018 · TR

Biomarker Rich Clinical Trial of an Innovative Antibody Antagonist of TNFR2 in Non-Hodgkin Lymphoma Featuring Cutaneous T Cell Lymphoma (CTCL).

$2,409,283
David G Brooks · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2025 · CA

Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy

$2,408,401
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL

THE THERAPY OF AML

$2,404,845
Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA

Targeted Therapies in Melanoma

$2,404,014
Meenhard Herlyn · Wistar Institute · P01 · FY2014 · CA

Center on the Microenvironment and Metastasis

$2,403,199
Michael L Shuler · Cornell University · U54 · FY2012 · CA

THE THERAPY OF AML

$2,401,083
Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA

Immunological Analysis of Brain Cancer

$2,394,103
Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Genetic Analysis of T-cell Differentiation

$2,388,750
Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Human Immune Responses to Tumor Antigens for Cancer Immunotherapy

$2,387,152
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

$2,385,495
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA

Tissue-specific stem cells and breast cancer tissue tropism

$2,385,000
Shelly R. Peyton · University Of Massachusetts Amherst · DP2 · FY2013 · CA

INTEGRATIVE PATHOPHYSIOLOGY OF SOLID TUMORS

$2,378,051
Massachusetts General Hospital · P01 · FY2004 · CA

Decoding the fundamental mechanisms of tumor emergence and evolution

$2,377,500
Carlos Carmona-Fontaine · New York University · DP2 · FY2019 · CA

Tracking tumor evolution through in vivo organelle profiling

$2,377,500
Rushika Miriam Perera · University Of California, San Francisco · DP2 · FY2016 · CA

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

$2,375,289
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2023 · CA

Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer

$2,375,000
George J Weiner · University Of Iowa · P50 · FY2017 · CA

THE THERAPY OF AML

$2,374,635
Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA

The Tisch Cancer Institute - Cancer Center Support Grant

$2,373,000
Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · P30 · FY2019 · CA

The Tisch Cancer Institute - Cancer Center Support Grant

$2,373,000
Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · P30 · FY2018 · CA

The Tisch Cancer Institute - Cancer Center Support Grant

$2,373,000
Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · P30 · FY2017 · CA

Cell surface proteolysis in development, tissue repair, and malignancy

$2,370,012
Thomas H Bugge · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE

SPORE in Prostate Cancer

$2,364,931
Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response

$2,361,658
Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2024 · CA

City of Hope Lymphoma SPORE

$2,359,066
Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA